Release Date June 15, 2017
Application Submission is now closed


Photo © Warren Zelman


Pharmaceutical systems strengthening is the process of identifying and implementing strategies and actions that achieve coordinated and sustainable improvements in the critical components of a pharmaceutical system to make it more responsive and resilient and to enhance its performance for achieving better health outcomes.

Health Policy Plan. 2017;32(4):572-584

Strengthening pharmaceutical systems entails implementing strategies and actions across critical components and functions of a system to improve and sustain performance and achieve better health outcomes.

What is the evidence base for strengthening and sustaining responsive and resilient pharmaceutical systems?

To answer this question, the USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program is issuing a call for case studies of sustained improvements in pharmaceutical systems in low- and middle-income countries (LMICs). The case studies should demonstrate how pharmaceutical systems strengthening strategies and actions have improved access to and appropriate use of pharmaceutical products and services for better health outcomes.

Accepted case studies will be published online and in print. Applicants may be asked to submit additional supporting documentation, data, or visuals to enhance their study. The authors of the selected case studies and their affiliation will be properly acknowledged in the collection.

Selection Criteria

All stakeholders are invited to submit case studies of interventions or programs addressing pharmaceutical systems strengthening in LMICs for consideration. Other health systems strengthening programs that have an impact on the pharmaceutical system may also submit case studies. Case studies will be selected based on the three criteria below. Learn more.

  1. A description of how specific strategies and actions strengthened the pharmaceutical system to improve access to and use of pharmaceutical products and services
  2. The inclusion of evidence that demonstrates sustained improvements in health systems performance and/or health outcomes resulting from pharmaceutical systems strengthening activities
  3. Actionable lessons and recommendations gained from implementation experiences

Submission Guidelines

Submissions should include a title, implementing entity, project timeframe, location, point of contact, and references. Submissions should not exceed 2,000 words.

The body of the case study should include the following:

  • Background: Context and problem statement
  • Implementation: Technical approach, strategies and actions
  • Results and lessons learned: Evidence generated from program activities
  • Conclusion: Brief discussion and practical, actionable recommendations

Global Call   |   Contact Us